Live
- Centre and Seers serious over Tirumala Sacrilege
- LG ELECTRONICS ORGANIZES GRAND TECH SEMINAR IN HYDERABAD
- Tirupati Laddus turns non-vegetarian Pilgrims from Karnataka begin shunning the temple
- analytica Anacon India, India Lab Expo, and Pharma Pro&Pack Expo to host the largest- ever edition in Hyderabad.
- JSW MG Motor India extends Industry-First ‘Battery-as-a-Service’ (BaaS) Program for Comet EV and ZS EV
- Saint-Gobain Gyproc India backs Gowhar Bilal to champion the 2024 World Skills Competition
- Controversy Over Alleged Use of Animal Fat in TTD Laddu Prasadam Sparks Calls for CBI Investigation
- MLA Bandla Krishnamohan Reddy Distributes Mahalakshmi Gas Cylinder Proceeding Letters to Thousands of Beneficiaries in Gadwal
- DK Aruna Demands Strict Punishment for Use of Animal Fat in Tirumala Laddu Preparation
- Samsung India’s AI-Powered ‘Big TV Festival’ Gets Bigger Than Ever This Festive Season; Avail Great Deals & Enjoy Unbeatable Offers on its Premium AI TV Range
Granules India divests entire stake in its arm
Highlights
Granules India Ltd on Tuesday said it has divested its entire stake in Granules-Biocause Pharmaceutical Co Limited, a joint venture company located in China.
Hyderabad: Granules India Ltd on Tuesday said it has divested its entire stake in Granules-Biocause Pharmaceutical Co Limited, a joint venture company located in China.
Last year, Granules India had intimated about the divestment of the entire stake of the JV company for a total consideration of RMB 109 million (around Rs 110.8 crore).
"The transaction is completed and Granules-Biocause Pharmaceutical Co Limited ceased to be the joint venture company of Granules India Limited," Granules India said in a regulatory filing.
Next Story
ADVERTISEMENT
